Stillbirth after occupational exposure to N-methyl-2-pyrrolidone. A case report and review of the literature.
暂无分享,去创建一个
[1] H. Taskinen. Nordic Criteria for Reproductive Toxicity , 1995, Journal of occupational and environmental medicine.
[2] F. Sullivan. The European Community Directive on the Classification and Labeling of Chemicals for Reproductive Toxicity , 1995, Journal of occupational and environmental medicine.
[3] C. Hansen,et al. Permeability of commercial solvents through living human skin. , 1995, American Industrial Hygiene Association journal.
[4] U. Hass,et al. Effects of prenatal exposure to N-methylpyrrolidone on postnatal development and behavior in rats. , 1994, Neurotoxicology and teratology.
[5] R. Pauli,et al. Wisconsin Stillbirth Service Program: I. Establishment and assessment of a community-based program for etiologic investigation of intrauterine deaths. , 1994, American journal of medical genetics.
[6] H. Taskinen,et al. Laboratory work and pregnancy outcome. , 1994, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[7] E. Zellers,et al. Modeling the temperature dependence of N-methylpyrrolidone permeation through butyl- and natural-rubber gloves. , 1993, American Industrial Hygiene Association journal.
[8] C. Edling,et al. High exposures to organic solvents among graffiti removers , 1993, International archives of occupational and environmental health.
[9] G. Engelhardt,et al. 1-Methyl-2-pyrrolidinone (NMP) does not induce structural and numerical chromosomal aberrations in vivo. , 1993, Mutation research.
[10] Feldman Gb. Prospective risk of stillbirth. , 1992 .
[11] K. Svendsen,et al. Irritant cutaneous reactions to N‐methyl‐2‐pyrrolidone (NMP) , 1992, Contact dermatitis.
[12] John M. Dement,et al. Cancer and Reproductive Risks Among Chemists and Laboratory Workers: A Review , 1992 .
[13] C. Curry. Pregnancy loss, stillbirth, and neonatal death. A guide for the pediatrician. , 1992, Pediatric clinics of North America.
[14] H. Beaulieu,et al. M-Pyrol™ (NMP) Use in the Microelectronics Industry , 1991 .
[15] P. Kussie,et al. Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives. , 1991, Toxicology letters.
[16] H. Kalter. Five-decade international trends in the relation of perinatal mortality and congenital malformations: stillbirth and neonatal death compared. , 1991, International journal of epidemiology.
[17] S. Swan,et al. Exposure to organic solvents and adverse pregnancy outcome. , 1991, American journal of industrial medicine.
[18] H. Taskinen,et al. Spontaneous abortions among women exposed to organic solvents. , 1990, American journal of industrial medicine.
[19] F. Zimmermann,et al. Induction of chromosome loss by mixtures of organic solvents including neurotoxins. , 1989, Mutation research.
[20] F. Zimmermann,et al. Aprotic polar solvents that affect porcine brain tubulin aggregation in vitro induce aneuploidy in yeast cells growing at low temperatures. , 1988, Mutation research.
[21] C. Goin,et al. Investigations of aneuploidy-inducing chemical combinations in Saccharomyces cerevisiae. , 1988, Mutation research.
[22] D. Wells,et al. Mutagenicity and cytotoxicity of n‐methyl‐2‐pyrrolidinone and 4‐(methylamino)butanoic acid in the Salmonella/microsome assay , 1988, Journal of applied toxicology : JAT.
[23] V. W. Mayer,et al. Aneuploidy induction in Saccharomyces cerevisiae by two solvent compounds, 1‐methyl‐2‐pyrrolidinone and 2‐pyrrolidinone , 1988, Environmental and molecular mutagenesis.
[24] K. P. Lee,et al. Toxicity of N-methyl-2-pyrrolidone (NMP): Teratogenic, subchronic, and two-year inhalation studies , 1987 .
[25] B. W. Barry,et al. Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug films, occlusion and the penetration enhancer N‐methyl‐2‐pyrrolidone , 1985, The Journal of pharmacy and pharmacology.
[26] R. A. Parent,et al. Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats. , 1982, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[27] B. Källén,et al. Pregnancy outcome for women working in laboratories in some of the pharmaceutical industries in Sweden. , 1980, Scandinavian journal of work, environment & health.
[28] B. Källén,et al. MAJOR MALFORMATIONS IN INFANTS BORN OF WOMEN WHO WORKED IN LABORATORIES WHILE PREGNANT , 1979, The Lancet.
[29] O. Axelson,et al. SPONTANEOUS ABORTIONS AMONG WOMEN IN HOSPITAL LABORATORY , 1978, The Lancet.